Silverio Loreta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Silverio Loreta has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Allegra
Division of Hematology, Department of Human Pathology in Adulthood and Childhood “Gaetano Barresi”, University of Messina, 98125 Messina, Italy
1 shared publication - Fabio Stagno
Division of Hematology, Department of Human Pathology in Adulthood and Childhood “Gaetano Barresi”, University of Messina, Via Consolare Valeria 1, 98125 Messina, Italy
1 shared publication - Gabriella Cancemi
Hematology Unit, Department of Human Pathology in Adulthood and Childhood “Gaetano Barresi”, University of Messina, Via Consolare Valeria, 98125 Messina, Italy
1 shared publication - Santino Caserta
Hematology Unit, Department of Onco-Hematology, Azienda Ospedaliera of Cosenza, 87100 Cosenza, Italy
1 shared publication
Latest Publications
- Open Access
- 29 June 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (13) , 1390
Hematological Malignancies in Older Patients: Focus on the Potential Role of a Geriatric Assessment Management
Geriatric assessment management is a multidimensional tool used to evaluate prognosis for clinical outcomes and targets for interventions in older adults with cancer receiving chemotherapy. In this review, we evaluated the possible application of geriatric assessment management (GAM) in hematological malignancies. In older patients with Diffuse Large B Cell Lymphoma, GAM might be helpful in both predicting planned hospital admissions and improving quality of life. In chronic myeloid leukemia, the Charlson Comorbidity Index demonstrates how comorbidities could affect treatment compliance and overall outcomes. In multiple myeloma, the application of different scores such as the International Myeloma Working Group Frailty Index and the Revised Myeloma Comorbidity Index can identify frail patients who need suitable interventions in treatment plan (reducing drug dose or changing treatment). Therefore, including GAM in the management plan of older patients with hematological malignancies may direct and optimize cancer care.
- 29 June 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (13) , 1390
Open AccessHematological Malignancies in Older Patients: Focus on the Potential Role of a Geriatric Assessment Management
Geriatric assessment management is a multidimensional tool used to evaluate prognosis for clinical outcomes and targets for interventions in older adults with cancer receiving chemotherapy. In this review, we evaluated the possible application of geriatric assessment management (GAM) in hematological malignancies. In older patients with Diffuse Large B Cell Lymphoma, GAM might be helpful in both predicting planned hospital admissions and improving quality of life. In chronic myeloid leukemia, the Charlson Comorbidity Index demonstrates how comorbidities could affect treatment compliance and overall outcomes. In multiple myeloma, the application of different scores such as the International Myeloma Working Group Frailty Index and the Revised Myeloma Comorbidity Index can identify frail patients who need suitable interventions in treatment plan (reducing drug dose or changing treatment). Therefore, including GAM in the management plan of older patients with hematological malignancies may direct and optimize cancer care.